AI assistant
INSMED Inc — Director's Dealing 2024
Sep 10, 2024
30150_dirs_2024-09-10_d9d4f287-bdf6-4b1f-9581-b32921148799.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-09-06
Reporting Person: Flammer Martina M.D. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-06 | Common Stock | M | 36555 | $18.95 | Acquired | 142689 | Direct |
| 2024-09-06 | Common Stock | M | 25740 | $26.46 | Acquired | 168429 | Direct |
| 2024-09-06 | Common Stock | M | 18874 | $23.66 | Acquired | 187303 | Direct |
| 2024-09-06 | Common Stock | M | 34280 | $26.43 | Acquired | 221583 | Direct |
| 2024-09-06 | Common Stock | M | 14130 | $23.75 | Acquired | 235713 | Direct |
| 2024-09-06 | Common Stock | M | 19423 | $17.07 | Acquired | 255136 | Direct |
| 2024-09-06 | Common Stock | S | 76455 | $70.90 | Disposed | 178681 | Direct |
| 2024-09-06 | Common Stock | S | 63483 | $71.43 | Disposed | 115198 | Direct |
| 2024-09-06 | Common Stock | S | 9064 | $72.61 | Disposed | 106134 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-06 | Stock Option (right to buy) | $18.95 | M | 36555 | Disposed | 2033-05-11 | Common Stock (36555) | Direct |
| 2024-09-06 | Stock Option (right to buy) | $26.46 | M | 25740 | Disposed | 2031-05-12 | Common Stock (25740) | Direct |
| 2024-09-06 | Stock Option (right to buy) | $23.66 | M | 18874 | Disposed | 2030-01-02 | Common Stock (18874) | Direct |
| 2024-09-06 | Stock Option (right to buy) | $26.43 | M | 34280 | Disposed | 2032-01-06 | Common Stock (34280) | Direct |
| 2024-09-06 | Stock Option (right to buy) | $23.75 | M | 14130 | Disposed | 2030-01-03 | Common Stock (14130) | Direct |
| 2024-09-06 | Stock Option (right to buy) | $17.07 | M | 19423 | Disposed | 2032-05-11 | Common Stock (19423) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 76,455 shares sold at prices ranging from $70.20 to $71.20 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 63,483 shares sold at prices ranging from $71.21 to $72.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 9,064 shares sold at prices ranging from $72.23 to $73.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
F6: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.